首页 | 本学科首页   官方微博 | 高级检索  
     

间期荧光原位杂交结合测序分析在慢性髓系白血病慢性期伊马替尼治疗监测中的应用
引用本文:张嵩,杜庆锋,刘晓力,欧阳昭,刘志. 间期荧光原位杂交结合测序分析在慢性髓系白血病慢性期伊马替尼治疗监测中的应用[J]. 医学争鸣, 2009, 0(16)
作者姓名:张嵩  杜庆锋  刘晓力  欧阳昭  刘志
作者单位:南方医科大学南方医院血液科;南方医科大学南方医院临床医学教育中心;
基金项目:广州市科技攻关重点引导项目(2006Z3-E0401)
摘    要:目的:探讨在慢性髓系白血病(CML)慢性期伊马替尼治疗中,间期荧光原位杂交(I-FISH)结合Abl酪氨酸激酶区测序技术对疗效监测、耐药分析及预后判断的意义.方法:应用双色双融合探针I-FISH对18例伊马替尼治疗获完全细胞遗传学缓解的CML慢性期患者骨髓内残留肿瘤细胞负荷进行检测,并对I-FISH检测阳性患者进行ABL酪氨酸激酶区测序分析.结果:双色双融合探针I-FISH的正常分界值为0.73%,18例伊马替尼治疗后患者检测中,8/18(44%)结果阳性;8例I-FISH检测阳性患者测序分析发现2例(25%)出现ABL激酶区点突变,点突变类型为E255K和T315I.结论:联合应用I-FISH和测序分析不仅能较灵敏、特异地监测伊马替尼治疗后肿瘤细胞负荷的变化,并可对药物疗效、耐药情况进行早期分析,有效地指导治疗和判断预后.

关 键 词:白血病  髓样  慢性  伊马替尼  原位杂交  荧光  点突变  

Application of interphase fluorescence in situ hybridization and sequencing analysis in imatinib treatment of patients with chronic myeloid leukemia in chronic phase
ZHANG Song,DU Qing-Feng,LIU Xiao-Li,OUYANG Zhao,LIU Zhi. Application of interphase fluorescence in situ hybridization and sequencing analysis in imatinib treatment of patients with chronic myeloid leukemia in chronic phase[J]. Negative, 2009, 0(16)
Authors:ZHANG Song  DU Qing-Feng  LIU Xiao-Li  OUYANG Zhao  LIU Zhi
Affiliation:ZHANG Song1,DU Qing-Feng2,LIU Xiao-Li1,OUYANG Zhao1,LIU Zhi1 1Department of Hematology,2Education Center of Clinical Medicine,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
Abstract:AIM:To explore the significance of interphase fluorescence in situ hybridization(I-FISH)and sequencing analysis in evaluating the curative effect,drug resistance and prognosis of imatinib treatment for patients with chronic myeloid leukemia(CML)in chronic phase(CP).METHODS:The tumor load was detected in 18 CML-CP cases with complete cytogenetic remission(CCR),who were treated with imatinib by dual-color and dual-fusion I-FISH(D-FISH).The point mutation of Abl kinase domain was analyzed in the patients with ...
Keywords:leukemia  myeloid  chronic  imatinib  in situ hybridization  fluorescence  point mutation  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号